Medpace Revenue and Competitors

Claim your profile

Location

$38.4M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Medpace's estimated annual revenue is currently $1.1B per year.(i)
  • Medpace's estimated revenue per employee is $235,931
  • Medpace's total funding is $38.4M.
  • Medpace's current valuation is $6.3B. (January 2022)

Employee Data

  • Medpace has 4620 Employees.(i)
  • Medpace grew their employee count by 20% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$683.2M275554%$1.8MN/A

The integrated services at Medpace include: clinical development plan preparation, project management, regulatory document preparation, safety surveillance, clinical monitoring, data management, statistical analysis, medical writing, quality assurance auditing, and US and international regulatory submissions. At Medpace, proven leaders in medical and scientific research monitor every project. The therapeutic focus and experience of the Medpace team, which includes on-staff physicians, reduces the need for client oversight, review, and training. In addition, Medpace physicians have first-hand experience working with regulatory agencies to successfully guide projects through the complexities of the regulatory process. The medical expertise and regulatory guidance provided by Medpace leads to reduced costs and increased efficiencies for our valued customers. Medpace brings together an exceptionally well-qualified team of medical and scientific personnel for every project. This team-based approach, combined with comprehensive training programs, active career development and cross-training opportunities, has significantly reduced attrition. This provides Sponsors with personalized service and the potential for long-term partnerships. Medpace offers a variety of leading edge technologies to track, interpret, and communicate information in the most timely, secure, and cost-effective manner. ClinTrak®, a web-based, proprietary research management system designed by Medpace, offers access to near real-time study data and metrics.

keywords:Biotechnology, Pharmaceuticals

$38.4M

Total Funding

4620

Number of Employees

$1.1B

Revenue (est)

20%

Employee Growth %

$6.3B

Valuation

N/A

Accelerator

Medpace News

2022-04-20 - Earnings Preview: Medpace Hldgs - Benzinga

Here's what investors need to know before the announcement. Analysts estimate that Medpace Hldgs will report an earnings per share (EPS) of...

2022-04-17 - SomaLogic (NASDAQ:SLGC) & Medpace (NASDAQ:MEDP ...

SomaLogic (NASDAQ:SLGC) & Medpace (NASDAQ:MEDP) Critical Analysis. Posted by admin on Apr 20th, 2022. Share on Twitter Share on Facebook Share on LinkedIn...

2022-04-06 - Medpace Holdings: Recent Price Dislocation, A Buying Opportunity.

Is Medpace RFP decline a sign of deterioration in the funding environment? After listening to and reviewing earnings calls and financial data...

2021-10-28 - Integrating Wearable Remote Biosensor Technology into Decentralized Clinical Trials, Upcoming Webinar Hosted by Xtalks

Join us as these experts share critical considerations and lessons learned in the integration and application of wearable devices into decentralized clinical trials (DCTs). TORONTO (PRWEB) October 28, 2021 In this webinar, Medpace, a global CRO with a specialized remote biosensor team, and Viv ...

2021-03-10 - Medpace Holdings, Inc. to Report First Quarter 2021 Financial Results on April 26, 2021

CINCINNATI--(BUSINESS WIRE)--Mar 10, 2021-- Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its first quarter 2021 financial results after the market close on Monday, April 26, 2021. The Company will host a conference call the following morning, Tuesday, Ap ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1911.9M50588%N/A
#2
$3095.9M506010%N/A
#3
$836.6M531412%N/A
#4
$1672.7M54310%N/A
#5
$1600.2M5443-1%N/A